SEC 13F Intelligence

Amova Asset Management Americas, Inc. / IOVA

Amova Asset Management Americas, Inc.’s Iovance Biotherapeutics Inc Position

Does Amova Asset Management Americas, Inc. own Iovance Biotherapeutics Inc (IOVA)? Not currently — the last reported position was 2.49M shares worth $18M in Q2 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$18M
Q2 2023
Shares
2.49M
% of Portfolio
+0.18%
Quarters Held
18
position exited

Position History IOVA

Reported value by quarter
Q1 ’19: $4MQ1 ’19Q2 ’19: $31MQ3 ’19: $25MQ4 ’19: $37MQ4 ’19Q1 ’20: $67MQ2 ’20: $75MQ3 ’20: $116MQ3 ’20Q4 ’20: $205MQ1 ’21: $169MQ2 ’21: $199MQ2 ’21Q3 ’21: $145MQ4 ’21: $83MQ1 ’22: $39MQ1 ’22Q2 ’22: $30MQ3 ’22: $25MQ4 ’22: $17MQ4 ’22Q1 ’23: $15MQ2 ’23: $18Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 20232.49M$18M+0.18%
Q1 20232.55M$15M+0.18%
Q4 20222.59M$17M+0.24%
Q3 20222.70M$25M+0.32%
Q2 20222.80M$30M+0.37%
Q1 20222.38M$39M+0.29%
Q4 20214.97M$83M+0.43%
Q3 20216.38M$145M+0.62%
Q2 20217.72M$199M+0.78%
Q1 20215.35M$169M+0.83%
Q4 20204.42M$205M+1.17%
Q3 20203.52M$116M+1.03%
Q2 20202.75M$75M+0.99%
Q1 20202.24M$67M+0.63%
Q4 20191.33M$37M+0.58%
Q3 20191.36M$25M+0.44%
Q2 20191.26M$31M+0.61%
Q1 2019463.1K$4M+0.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Amova Asset Management Americas, Inc.’s full portfolio or all institutional holders of IOVA.